References

Grow Taller 4 Idiots

How to Grow Taller

Get Instant Access

1. Beck JC, McGarry EE, Dyrenfurth I, Venning EH. Metabolic effects of human and monkey growth hormone in man. Science 1957;125:884,885.

2. Raben MS. Treatment of a pituitary dwarf with human growth hormone. J Clin Endocrinol Metab 1958;18:901-903.

3. Isaksson OGP, Lindahl A, Nilsson A, Isgaard J. Mechanism of stimulatory effect of growth hormone on longitudinal bone growth. Endocr Rev 1987;8:426-438.

4. Eden S, Isaksson OGP, Madsen K, Friberg U. Specific binding of growth hormone to isolated chondrocytes from rabbit ear and epiphyseal plate. Endocrinology 1983;112:1127-1129.

5. Werther GA, Haynes KM, Barnard R, Waters MJ. Visual demonstration of growth hormone receptors on human growth plate chondrocytes. J Clin Endocrinol Metab 1990;70:1725-1731.

6. Ernst M, Froesch ER. Growth hormone dependent stimulation of osteoblast-like cells in serum-free cultures via local synthesis of insulin-like growth factor I. Biochem Biophys Res Comm 1988;151:142-147.

7. Slootweg MC, van Buul-Offers SC, Herrmann-Erlee MPM, Duursma SA. Direct stimulatory effect of growth hormone on DNA synthesis of fetal chicken osteoblasts in culture. Acta Endocrinol 1988;118:294-300.

8. Hock JM, Centrella M, Canalis E. Insulin-like growth factor I has independent effects on bone matrix formation and cell replication. Endocrinology 1988;122:254-260.

9. McCarthy TL, Centrella M, Canalis E. Regulatory effects of insulin-like growth factors I and II on bone collagen synthesis in rat calvarial cultures. Endocrinology 1989;124:301-309.

10. Barnard R, Ng KW, Martin TJ, Waters MJ. Growth hormone (GH) receptors in clonal osteoblast-like cells mediate a mitogenic response to GH. Endocrinology 1991;128:1459-1464.

11. Centrella M, McCarthy TL, Canalis E. Receptors for insulin-like growth factors-I and -II in osteoblast-enriched cultures from fetal rat bone. Endocrinology 1990;126:39-44.

12. Ernst M, Rodan GA. Increased activity of insulin-like growth factor (IGF) in osteoblastic cells in the presence of growth hormone (GH): positive correlation with the presence of the GH-induced IGF-binding protein BP-3. Endocrinology 1990;127:807-814.

13. Spanos E, Barrett D, MacIntyre I, Pike JW, Safilian EF, Haussler MR. Effect of growth hormone on vitamin D metabolism. Nature 1978;273:246-247.

14. Gray RW, Garthwaite TL. Activation of renal 1, 25-dihydroxyvitamin D3 synthesis by phosphate deprivation: evidence for a role for growth hormone. Endocrinology 1985;116:189-193.

15. Harris WH, Heaney RP. Effect of growth hormone on skeletal mass in adult dogs. Nature 1969;223: 403,404.

16. Harris WH, Heaney RP, Jowsey J, Cockin J, Akins C, Graham J, et al. Growth hormone: the effect of skeletal renewal in the adult dog. Calc Tiss Res 1972;10:1-13.

17. Shore RM, Chesney RW, Mazess RB, Rose PG, Bargman GJ. Bone mineral status in growth hormone deficiency. J Pediatr 1980;96:393-396.

18. Degerblad M, Almkvist O, Grunditz R, Hall K, Kaijser L, Knutsson E, et al. Physical and psychological capabilities during substitution therapy with recombinant growth hormone in adults with growth hormone deficiency. Acta Endocrinol 1990;123:185-193.

19. Kaufman JM, Taelman P, Vermeulen A, Vandeweghe M. Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset. J Clin Endocrinol Metab 1992;74:118-123.

20. Rosen T, Hansson T, Granhed H, Szucs J, Bengtsson B-A. Reduced bone mineral content in adult patients with growth hormone deficiency. Acta Endocrinol 1993;129:201-206.

21. Johansson AG, Burman P, Westermark K, Ljunghall S. The bone mineral density in acquired growth hormone deficiency correlates with circulating levels of insulin-like growth factor I. J Int Med 1992;232:447-452.

22. Bing-You RG, Denis M-C, Rosen CJ. Low bone mineral density in adults with previous hypotha-lamic-pituitary tumors: correlations with serum growth hormone responses to GH-releasing hormone, insulin-like growth factor I, and IGF binding protein 3. Calcif Tiss Int 1993:52:183-187.

23. Holmes SJ, Economou G, Whitehouse RW, Adams JE, Shalet SM. Reduced bone mineral density in patients with adult onset growth hormone deficiency. J Clin Endocrinol Metab 1994;78:669-674.

24. Corpas E, Harman SM, Blackman MR. Human growth hormone and human aging. Endocr Rev 1993;14:20-39

25. Rudman D. Growth hormone, body composition and aging. J Am Geriatr Soc 1985;33:800-807.

26. Dequeker J, Burssens A, Bouillon R. Dynamics of growth hormone secretion in patients with osteoporosis and in patients with osteoarthrosis. Hor Res 1982;16:353-356.

27. Wuster C, Blum WF, Schlemilch S, Ranke MB, Ziegler. Decreased serum levels of insulin-like growth factors and IGF binding protein 3 in osteoporosis. J Int Med 1993;234:249-255.

28. Nielsen HK, Jorgensen JOL, Brixen K, Christiansen JS. Serum osteoclacin and bone isoenzyme alkaline phosphatase in growth hormone-deficient patients: dose-response studies with biosynthetic human GH. Calcif Tiss Int 1991;48:82-87.

29. Zamboni G, Antoniazzi F, Radetti G, Musumeci C, Tato L. Effects of two different regimens of recombinant human growth hormone therapy on the bone mineral density of patients with growth hormone deficiency. J Pediatr 1991;119:483-485.

30. Jensen LT, Jorgensen JOL, Risteli J, Christiansen JS, Lorenzen I. Type I and III procollagen propeptides in growth hormone-deficient patients: effects of increasing doses of GH. Acta Endocrinol 1991;124:278-282.

31. Saggese G, Baroncelli GI, Bertelloni S, Cinquanta L, Di Nero G. Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency. J Pediatr 1993;122:37-45.

32. Johansen JS, Pedersen SA, Jorgensen JOL, Riis BJ, Christiansen C, Christiansen JS et al. Effects of growth hormone (GH) on plasma bone Gla protein in GH-deficient adults. J Clin Endocrinol Metab 1990;70:916-919.

33. Schlemmer A, Johansen JS, Pedersen SA, Jorgensen JOL, Hassager C, Christiansen C. The effect of growth hormone (GH) therapy on urinary pyridinoline cross-links in GH-deficient adults. Clin Endocrinol 1991;35:471-476.

34. Whitehead HM, Boreham C, Mcllrath EM, Sheridan B, Kennedy L, Atkinson AB et al. Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study. Clin Endocrinol 1992;36:45-52.

35. Degerblad M, Elgindy N, Hall K, Sjoberg H-E, Thoren M. Potent effect of recombinant growth hormone on bone mineral density and body composition in adults with panhypopituitarism. Acta Endocrinol 1992;126:387-393.

36. Vandeweghe M, Taelman P, Kaufman J-M. Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males. Clin Endocrinol 1993;39:409-415.

37. Juul A, Pedersen SA, Sorensen S, Winkler K, Jorgensen JOL, Christiansen JS et al. Growth hormone (GH) treatment increases serum insulin-like growth factor binding protein-3, bone isoenzyme alkaline phosphatase and forearm mineral content in young adults with GH deficiency of childhood onset. Eur J Endocrinol 1994;131:41-49.

38. O'Halloran DJ, Tsatsoulis A, Whitehouse RW, Holmes SJ, Adams JE, Shalet SM. Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency. J Clin Endocrinol Metab 1993;76:1344-1348.

39. Balducci R, Toscano V, Pasquino AM, Mangiantini A, Municchi G, Armenise P, et al. Bone turnover and bone mineral density in young adult patients with panhypopituitarism before and after long-term growth hormone therapy. Eur J Endocrinol 1995;132:42-46.

40. Diamond T, Nery L, Posen S. Spinal and peripheral bone mineral densities in acromegaly: the effects of excess growth hormone and hypogonadism. Ann Intern Med 1989;111:567-573.

41. Kotzmann H, Bernecker P, Hubsch P, Pietschmann P, Woloszczuk W, Svoboda T et al. Bone mineral density and parameters of bone metabolism in patients with acromegaly. J Bone Miner Res 1993;8:459-465.

42. Bengtsson BA, Eden S, Lonn L, Kvist H, Stokland A, Lindstedt G, et al. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab 1993;76:309-317.

43. Rosen T, Johannsson G, Hallgren P, Caidahl K, Bosaeus I, Bengtsson B-A. Beneficial effects of 12 months replacement therapy with recombinant human growth hormone to growth hormone deficient adults. Endocrinology and Metabolism 1994;1:55-56.

44. Johannsson G, Rosen T, Bosaeus I, Sjostrom L, Bengtsson B. Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency. J Clin Endocrinol Metab 1996;81:2865-2873.

45. Beshayah SA, Thomas E, Kyd P, Sharp P, Fairney A, Johnston DG. The effect of growth hormone replacement therapy in hypopituitary adults on calcium and bone metabolism. Clin Endocrinol 1994;40:383-391.

46. Hansen TB, Brixen K, Vahl N, Jorgensen JOL, Christiansen JS, Mosekilde L, Hagen C. Effects of 12 months of growth hormone (GH) treatment on calciotropic hormones, calcium homeostasis, and bone metabolism in adults with acquired GH deficiency: a double blind, randomized, placebo-controlled study. J Clin Endocrinol Metab 1996;81:3352-3359.

47. Holmes SJ, Whitehouse RW, Swindell R, Economou G, Adams JE, Shalet SM. Effect of growth hormone replacement on bone mass in adults with adult onset growth hormone deficiency. Clin Endocrinol 1995;42:627-633.

48. Baum HBA,Biller BMK, Finkelstein JS, Cannistraro KB, Oppenheim DS, Schoenfeld DA, et al. Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. A randomized, placebo-controlled trial. Ann Intern Med 1996;125:883-890.

49. Aloia JF, Zanzi I, Ellis K, Jowsey J, Roginsky M, Wallach S, et al. Effects of growth hormone in osteoporosis. J Clin Endocrinol Metab 1976;43:992-999.

50. Aloia JF, Vaswani A, Kapoor A, Yeh JK, Cohn SH. Treatment of osteoporosis with calcitonin, with and without growth hormone. Metabolism 1985;34:124-129.

51. Aloia JF, Vaswani A, Meunier PJ, Edouard CM, Arlot ME, Yeh JK, et al. Coherence treatment of post menopausal osteoporosis with growth hormone and calcitonin. Calcif Tiss Int 1987;40:253-259.

52. Marcus R, Butterfield G, Holloway L, Gilliland L, Baylink DJ, Hintz RL, et al. Effects of short term administration of recombinant human growth hormone to elderly people. J Clin Endocrinol Metab 1990;70:519-527.

53. Holloway L, Butterfield G, Hintz RL, Geshundheit N, Marcus R. Effects of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in health elderly women. J Clin Endocrinol Metab 1994;79:470-479.

54. Rudman D, Feller AG, Hoskote S, Nagraj HS, Gergans GA, Lalitha PY, Goldberg AF, et al. Effects of growth hormone in men over 60 years old. N Engl J Med 1990;323:1-6.

55. Rudman D, Feller AG, Cohn L, Shetty KR, Rudman IW, Draper MW. Effects of human growth hormone on body composition in elderly men. Hor Res 1991;36(Suppl 1):73-81.

Was this article helpful?

0 0
Natural Cures For Menopause

Natural Cures For Menopause

Are Menopause Symptoms Playing Havoc With Your Health and Relationships? Are you tired of the mood swings, dryness, hair loss and wrinkles that come with the change of life? Do you want to do something about it but are wary of taking the estrogen or antidepressants usually prescribed for menopause symptoms?

Get My Free Ebook


Post a comment